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Objective and accurate measures of the gait of MS patients are necessary
most important source of disability [1].
- Most patients with MS have
walking difficulties.
- They are often perceived by them as the




- When the symptoms are clearly identified, it is
possible to help the patients (e.g. with physical
therapy).
Detecting the early
stage to give a chance to
effective treatments. - There does not exist any drug to
cure MS. The best would be to block
the disease progression.
- Ambulation impairments often appear during
the early stages of the disease.
To avoid attacks,
but also the steady decline
that is slow and barely
noticeable.
- Gait modification is a good
indicator of disease activity [2].
- Clinico-radiological paradox: the MRI and
the clinical symptoms are not well correlated.
In the progressive forms, this is even worse.
Statistically
demonstrating the
efficacy of drugs and
physiotherapy.
- Correlations between the disease’s
progression and the gait impairments
⇒ can be used for drugs focusing on the cause.
- There are drugs specifically designed to help
reducing the symptoms (especially on gait).
- Correlations between the gait characteristics and
the quantity and quality of physical therapy [3].
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Why? Why? Why? Why?
The gait measuring system GAIMS
In general, all gait impairments have an impact on the movement of the lower limbs ex-
tremities. Neurologists qualitatively look at the feet movements. GAIMS also observe their
movements, but measure them quantitatively, thanks to a set of range laser sensors scanning
a common plane a few centimeters above the floor. It is reliable (e.g. the measures are not
affected by the colors of clothes or the lighting conditions) and does not require to equip the
patients with any marker or sensor.
Figure: Example of setup. The 25 ft straight path is shown in green, a 20m ∞-shaped path is shown in
orange, and the SSST spots are shown in blue. A few laser rays (invisible in reality) are shown in red. The
range laser devices (BEA LZR-i100) are in small enclosures in the corners of the room.
The use of GAIMS with MS patients in clinical routine
•We can draw a 25 ft straight path on the floor and ask the patients to follow it, to
perform the standardized test.
•We can draw a ∞-shaped path on the floor and ask the patients to follow it several laps
to observe the motor fatigue [2] on long distances, or to perform the 6 minutes test.
•We can draw the 6 spots of the SSST to analyze the feet movements during it.
•We can ask the patients to walk in different modes (at preferred pace, as fast as possible,
or in tandem gait).
•GAIMS provides quantitative and objective measures such as the deviation from the
followed path, the speed, the inter-feet distance, the cadence, the stride length, the gait
asymmetry, the temporal variability, the proportion of double support time, etc.
Comparison of GAIMS with other systems
compatible with the standardized
tests (25 ft, 6 minutes walk, SSST)
⇒ detect when a foot moves over
a given point (start/stop lines, spot)
able to analyze the gait on long
distances without a treadmill
(gait is different on the ground
than on a treadmill)
low cost
reliable
satisfies the constraints of
the clinical routine (no time
necessary to equip the patients
+ avoid getting them tired)
from the path the patient wants to follow, etc.)
affected by the disease (ataxia, deviation
able to highlight the main gait characteristics
areas without occlusions
or loss of signal
captures the gait in large
captures the gait in both the
swing and stance phases and
is able to distinguish the two
GAIMS
electronic walkway (e.g. GAITRite)
marker-based motion capture
color camera and computer vision
inertial system (e.g. accelerometers)
stopwatch
The reference database
•This is an ongoing project, so its size is still increasing
• 71 patients with MS (27 with an EDSS ∈ [1.5, 3] and 44 with an EDSS ∈ [3.5, 5.5])
• 129 healthy volunteers
test 1 2 3 4 5 6 7 8 9 10 11 12
distance
25 Ft • • • • • •
20 m • • •
100 m • •
500 m •
mode
comfortable • • • •
as fast as possible • • • • •
tandem • • •
What is done in the project GAIMS












ments similar to those of
MS patients, at the first visit)
algorithms to identify the feet (left/right), compute their trajectories, and describe them
with objective and quantitative quantities: the gait descriptors (e.g. the deviation from the
MS, with various morphological characteristics (age, weight, height, ...) and disease levels
reference database with gait descriptors of many healthy persons and patients with
based on the observations [4]
ration between successive visits [5])
diagnosis of MS [6, 7]
hardware, based on existing range laser scanners (perennial solution),
with the driver and an accurate calibration procedure [8]
HELP WANTED !
for a multicentric approach
algorithms to localize the feet with high precision and accuracy, even in
case of occlusions, unsynchronized sensors, and high walking speed [9]
followed path, the speed, the double support time, the mean clearance between the feet, etc)
high level information
to ease the interpretation
low level
information
and of the probabilities of gait
Visit our website ! http://www.montefiore.ulg.ac.be/gaims/
Results
diagnosis of MS prediction of EDSS
(AUC = 0.97) (ρ = 0.86, RMSE = 1.11)
stability or modification? deterioration or improvement?
(ataxia induced by alcohol intake) (ataxia induced by alcohol intake)
























True Negative Rate (%)
results obtained by leave-one-out, with 1001 trees and 50 pairs of visits
test 1 (25ft, comfortable, 1st try) : AUC = 0.892
test 2 (25ft, comfortable, 2nd try) : AUC = 0.835
test 3 (25ft, as fast as possible, 1st try) : AUC = 0.815
test 4 (25ft, as fast as possible, 2nd try) : AUC = 0.824
test 5 (25ft, tandem gait, 1st try) : AUC = 0.812
test 6 (25ft, tandem gait, 2nd try) : AUC = 0.820
test 7 (20m, comfortable, 1st try) : AUC = 0.849
test 8 (20m, as fast as possible, 1st try) : AUC = 0.808
test 9 (20m, tandem gait, 1st try) : AUC = 0.791
test 10 (100m, comfortable, 1st try) : AUC = 0.777
test 11 (100m, as fast as possible, 1st try) : AUC = 0.746
combination with a majority vote : AUC = 0.842
combination with the ’mean’ rule : AUC = 0.871
combination with the ’min’ rule : AUC = 0.853
combination with the ’max’ rule : AUC = 0.845
























True Negative Rate (%)
results obtained by leave-one-out, with 1001 trees and 23 pairs of visits
test 1 (25ft, comfortable, 1st try) : AUC = 0.927
test 2 (25ft, comfortable, 2nd try) : AUC = 0.976
test 3 (25ft, as fast as possible, 1st try) : AUC = 0.970
test 4 (25ft, as fast as possible, 2nd try) : AUC = 0.850
test 5 (25ft, tandem gait, 1st try) : AUC = 0.750
test 6 (25ft, tandem gait, 2nd try) : AUC = 0.794
test 7 (20m, comfortable, 1st try) : AUC = 0.731
test 8 (20m, as fast as possible, 1st try) : AUC = 0.620
test 9 (20m, tandem gait, 1st try) : AUC = 0.708
test 10 (100m, comfortable, 1st try) : AUC = 0.694
test 11 (100m, as fast as possible, 1st try) : AUC = 0.883
combination with a majority vote : AUC = 0.951
combination with the ’mean’ rule : AUC = 0.973
combination with the ’min’ rule : AUC = 0.894
combination with the ’max’ rule : AUC = 0.894
combination with the ’probabilistic product’ rule : AUC = 0.965
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